DK1267915T3 - Activated protein C for the treatment of pancreatitis - Google Patents

Activated protein C for the treatment of pancreatitis

Info

Publication number
DK1267915T3
DK1267915T3 DK01918217T DK01918217T DK1267915T3 DK 1267915 T3 DK1267915 T3 DK 1267915T3 DK 01918217 T DK01918217 T DK 01918217T DK 01918217 T DK01918217 T DK 01918217T DK 1267915 T3 DK1267915 T3 DK 1267915T3
Authority
DK
Denmark
Prior art keywords
pancreatitis
treatment
activated protein
protein
activated
Prior art date
Application number
DK01918217T
Other languages
Danish (da)
Inventor
Brian William Grinnell
Bryan Edward Jones
Angelina Vucic Ciaccia
Lawrence Mark Gelbert
David Eugene Joyce
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from EP01918217A external-priority patent/EP1267915B1/en
Application granted granted Critical
Publication of DK1267915T3 publication Critical patent/DK1267915T3/en

Links

DK01918217T 2000-03-28 2001-03-21 Activated protein C for the treatment of pancreatitis DK1267915T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19275500P 2000-03-28 2000-03-28
EP01918217A EP1267915B1 (en) 2000-03-28 2001-03-21 Activated protein c for treating pancreatitis
PCT/US2001/005823 WO2001072328A2 (en) 2000-03-28 2001-03-21 Methods of treating diseases with activated protein c

Publications (1)

Publication Number Publication Date
DK1267915T3 true DK1267915T3 (en) 2005-09-05

Family

ID=34921274

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01918217T DK1267915T3 (en) 2000-03-28 2001-03-21 Activated protein C for the treatment of pancreatitis

Country Status (1)

Country Link
DK (1) DK1267915T3 (en)

Similar Documents

Publication Publication Date Title
DK1259512T3 (en) Pteridine compounds for the treatment of psoreasis
NO2012018I1 (en) Canakinumab or direct equivalents thereof
DK1663287T3 (en) Use of modified cyclosporins for the treatment of HCV diseases
DK1147083T3 (en) Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
AR028253A1 (en) INHIBITORS OF THE GLUCOGENO FOSFORILASA
DK1427285T3 (en) Anthranilamide arthropodicide treatment
DK1343773T3 (en) Thiazole derivatives for the treatment of PPAR-related disorders
DE60126838D1 (en) Amidoacetonitriles for the control of endoparasites
ID30590A (en) ONCE USE SHORT TYPE OF SHORT-PANTS
DK1803718T3 (en) 4-Tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
DK1282616T3 (en) Hydroxyphenylpiperidin-4-ylidene methylbenzamide derivatives for the treatment of pain
DE60136477D1 (en) RETINOIDES FOR THE TREATMENT OF EMPHYSEM
DK1448205T3 (en) Combinations for the treatment of immuno-inflammatory diseases
NO20032122L (en) Improved treatment
DK1392318T3 (en) 15-keto-prostaglandins for the treatment of drug-induced constipation
DK1411926T3 (en) Integrin inhibitors for the treatment of eye diseases
DE60202489D1 (en) LYSIN-CONTAINING CARTRIDGE
EE200200632A (en) Preparations containing glucocorticoids for the treatment of bronchopulmonary disorders
DK1197485T3 (en) Cyclobutenedione dione derivatives for the treatment of artherosclerosis
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776L (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
DE60227963D1 (en) TREATMENT SYSTEM
DK1268482T3 (en) Pyranoindoles for the treatment of glaucoma
DK1461042T3 (en) Use of desoxypeganine in the treatment of clinical depression
DK1390364T3 (en) Aryl-8-azabicyclo [3.2.1] octanes for the treatment of depression